Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 4Not yet recruiting 2Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pleural Effusion, Malignant 1

Interventions

Carboplatin 7Paclitaxel 6Talc 5Docetaxel 5Bevacizumab 4Taxes 3Gemcitabine 3Cisplatin 3Trastuzumab 2High-Energy Shock Waves 2Erlotinib Hydrochloride 2Doxycycline 2Cetuximab 2Bortezomib 2viscum album peptide 1tipifarnib 1saracatinib 1romidepsin 1endostar protein 1Zoledronic Acid 1Vinorelbine 1Valacyclovir 1Tyrosine Kinase Inhibitors 1Thoracoscopy 1Thoracoscopes 1Thoracic Surgery, Video-Assisted 1Thoracentesis 1Surveys and Questionnaires 1Sorafenib 1Povidone-Iodine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Pleural Effusion, Malignant × Pleurodesis × Clear all
NCT01670786 2014-05-13

Safety Profile of Iodopovidone as an Agent for Pleurodesis in Malignant Pleural Effusion

Grupo de Pesquisa em Pleura e Oncologia Toracica

Phase 4 Completed
60 enrolled
Thoracic

Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡